imidocarb has been researched along with atovaquone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Gray, JS; Pudney, M | 1 |
Barker, R; Bhoora, R; Leisewitz, AL; Matjila, PT; Penzhorn, BL | 1 |
Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N | 1 |
Abdel-Daim, MM; Alkhoudary, MS; Alsharif, KF; El-Sayed, SAE; Igarashi, I; Rizk, MA | 1 |
Baghdadi, HB; El-Sayed, SAE; Eltaysh, R; Igarashi, I; Rizk, MA | 1 |
5 other study(ies) available for imidocarb and atovaquone
Article | Year |
---|---|
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Gerbillinae; Humans; Imidocarb; Naphthoquinones; Pentamidine; Recurrence | 1999 |
Molecular characterisation of Babesia gibsoni infection from a pit-bull terrier pup recently imported into South Africa.
Topics: Animals; Animals, Newborn; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia; Babesiosis; Disease Transmission, Infectious; DNA, Protozoan; Dog Diseases; Dogs; Drug Therapy, Combination; Imidocarb; Phylogeny; South Africa; Treatment Outcome; United States | 2007 |
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction | 2017 |
Compounds from the Medicines for Malaria Venture Box Inhibit In Vitro Growth of
Topics: Animals; Antiprotozoal Agents; Atovaquone; Babesia; Babesiosis; Blood-Borne Pathogens; Diminazene; Humans; Imidocarb; Malaria; Plants, Medicinal | 2021 |
Repurposing of the Malaria Box for Babesia microti in mice identifies novel active scaffolds against piroplasmosis.
Topics: Animals; Atovaquone; Babesia microti; Babesiosis; Clofazimine; Cysteine Proteases; Drug Repositioning; Imidocarb; Malaria; Mice; Theileria | 2022 |